]>
IRCT20181230042179N1 IRCT 2019-11-30 Mashhad University of Medical Sciences The Effectiveness of Henna Topical Formulation for the Prevention and Control of Hand-Foot Syndrome Study of the Effectiveness of Henna Topical Formulation for the Prevention and Control of Hand-Foot Syndrome Complicated by Capsitibine in Patients with Different Malignancies 2019-10-23 anticipated 40 Complete https://irct.ir/trial/42951 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization, randomly allocate a participant to a treatment group. Prepared a list of all permutations for the sample size, selected one of them and based on arrangement allocated participants to a treatment and control groups with sealed envelope. Participants will be unaware of the type of intervention. Investigator will be unaware of the type of intervention, Blinding description: After obtaining informed consent, participants were classified into intervention groups and were not aware of the type of intervention. Researcher and Care provider unaware of the type of intervention when investigate complications and treatment . 2-3 Condition 1: Malignant neoplasm Cancer. Condition 2: Malignant neoplasm Cancer. Intervention 1: Intervention group: topical henna formulation. Intervention 2: Control group: placebo ointment. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information
public Sareh Hosseini
mashhad univesity of medical science, Azadi Square, Vakil Abad Avenue, Mashhad, Iran.
Mashhad Iran (Islamic Republic of) 9177948964 +98 51 3884 6710 HOSSEINIS@MUMS.AC.IR Mashhad University of Medical Sciences scientific Sareh Hosseini
mashhad univesity of medical science, Azadi Square, Vakil Abad Avenue, Mashhad, Iran.
Mashhad Iran (Islamic Republic of) 9177948964 +98 51 3884 6710 HOSSEINIS@MUMS.AC.IR Mashhad University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Cancer Patients Candidate for Capsitibine Therapy 18 years no limit Both Increased liver enzymes increased blood creatinine fever, and severe neutropenia that need to be stopped Having Diabetes Use of immunosuppressant and anti-inflammatory drugs Having autoimmune diseases C00 C96 Malignant neoplasm of lip Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue Treatment - Drugs Treatment - Drugs Intervention group: topical henna formulation Control group: placebo ointment Side effects. Timepoint: Once a week for up to two months after intervention. Method of measurement: NCI Criteria. Mashhad University of Medical Sciences Approved 2019-01-01 Ethics committee of Mashhad University of Medical Sciences Building Ghoreshi, Central Organization of Mashhad University of Medical Sciences, Daneshgah Avenue Mashhad Razavi Khorasan Iran (Islamic Republic of)